ArticleFrontiers in immunology2026
Telitacicept for refractory AChR-positive generalized myasthenia gravis: a retrospective real-world study.
Xi Rong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it